Acetaminophen is owned by Fresenius Kabi Usa.
Acetaminophen contains Acetaminophen.
Acetaminophen has a total of 1 drug patent out of which 0 drug patents have expired.
Acetaminophen was authorised for market use on 28 October, 2015.
Acetaminophen is available in solution;intravenous dosage forms.
The generics of Acetaminophen are possible to be released after 19 April, 2030.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US8741959||FRESENIUS KABI USA||Paracetamol for parenteral administration|| |
(7 years from now)
Drugs and Companies using ACETAMINOPHEN ingredient
Market Authorisation Date: 28 October, 2015
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic